scispace - formally typeset
G

Ghayathri Balasundaram

Researcher at Agency for Science, Technology and Research

Publications -  43
Citations -  1415

Ghayathri Balasundaram is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Molecular imaging & Medicine. The author has an hindex of 14, co-authored 38 publications receiving 953 citations. Previous affiliations of Ghayathri Balasundaram include National University of Singapore.

Papers
More filters
Journal ArticleDOI

A Review of Clinical Photoacoustic Imaging: Current and Future Trends

TL;DR: This review provides an overview of the rapidly expanding clinical applications of photoacoustic imaging including breast imaging, dermatologic imaging, vascular imaging, carotid artery imaging, musculoskeletal imaging, gastrointestinal imaging and adipose tissue imaging and the future directives utilizing different configurations of photoACoustic imaging.
Journal ArticleDOI

Actively Targeted In Vivo Multiplex Detection of Intrinsic Cancer Biomarkers Using Biocompatible SERS Nanotags

TL;DR: This study establishes SERS nanotags as an ultrasensitive nanoprobe for the multiplex detection of biomarkers and opens up its potential application in monitoring tumor progression and therapy and development into a theranostic probe.
Journal ArticleDOI

Multifunctional Photosensitizer-Based Contrast Agents for Photoacoustic Imaging

TL;DR: The efficacy of various photosensitizers that are widely used as photodynamic therapeutic (PDT) agents as photoacoustic contrast agents are evaluated for the first time to demonstrate the potential of photosenitizers asphotoacoustic imaging contrast agents in vivo.
Journal ArticleDOI

Sensitive multiplex detection of serological liver cancer biomarkers using SERS-active photonic crystal fiber probe

TL;DR: An ultrasensitive platform for the multiplex detection of cancer biomarkers by combining the SERS technique with a hollow‐core photonic crystal fiber (HCPCF) and antibody‐conjugated SERS‐active nanoparticles (SERS nanotags) is developed.